MetaBiom
Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Acute lymphoblastic leukemia {40000486}

Record Keys


Definition:
Acute lymphoblastic leukemia
Class:[  ]

Details


Other Terms:
ALL
Initialisation date:[  ]

Meta Information


ICD:[  ]
Category:[  ]
MedDra ID:
10000846
MedDra Level:
pt

Notes


[  ]

Shared Notes


[  ]


[Coverage other Diseases (Overlap > 0.25)]

DiseaseOverlapCommon increased OrganismCommon decreased Organism
Acute lymphoblastic leukemia 1.0000 3 (100%) : Bacteriodes uniformis | Bacteroides | Bacteroides fragilis 14 (100%) : Alistipes | Anaerococcus | Atopobium | Bifidobacterium | Campylobacter | Corynebacterium | Faecalibacterium | Fusicatenibacter | Peptoniphilus | Porphyromonas | Prevotella | Pseudobutyrivibrio | Staphylococcus | Veillonellaceae
Type 1 diabetes 0.6786 3 (100%) : Bacteriodes uniformis | Bacteroides | Bacteroides fragilis 5 (36%) : Alistipes | Bifidobacterium | Faecalibacterium | Prevotella | Staphylococcus
Autism 0.6548 2 (67%) : Bacteroides | Bacteroides fragilis 9 (64%) : Alistipes | Atopobium | Bifidobacterium | Corynebacterium | Fusicatenibacter | Peptoniphilus | Porphyromonas | Prevotella | Veillonellaceae
Colorectal cancer 0.5476 2 (67%) : Bacteroides | Bacteroides fragilis 6 (43%) : Alistipes | Atopobium | Bifidobacterium | Faecalibacterium | Prevotella | Staphylococcus
Obesity 0.5119 2 (67%) : Bacteroides | Bacteroides fragilis 5 (36%) : Alistipes | Atopobium | Bifidobacterium | Faecalibacterium | Prevotella
Kidney stone 0.4762 2 (67%) : Bacteroides | Bacteroides fragilis 4 (29%) : Faecalibacterium | Fusicatenibacter | Peptoniphilus | Prevotella
Ulcerative Colitis 0.4405 2 (67%) : Bacteroides | Bacteroides fragilis 3 (21%) : Alistipes | Bifidobacterium | Prevotella
Type 2 diabetes 0.4167 1 (33%) : Bacteroides 7 (50%) : Atopobium | Bifidobacterium | Campylobacter | Faecalibacterium | Peptoniphilus | Prevotella | Staphylococcus
Cystic fibrosis 0.4167 1 (33%) : Bacteroides 7 (50%) : Alistipes | Bifidobacterium | Campylobacter | Corynebacterium | Faecalibacterium | Porphyromonas | Prevotella
Multiple Sclerosis 0.4048 2 (67%) : Bacteroides | Bacteroides fragilis 2 (14%) : Faecalibacterium | Prevotella
Crohn's disease 0.3452 1 (33%) : Bacteroides fragilis 5 (36%) : Alistipes | Bifidobacterium | Faecalibacterium | Prevotella | Veillonellaceae
Atopic Dermatitis 0.3452 1 (33%) : Bacteroides 5 (36%) : Atopobium | Bifidobacterium | Corynebacterium | Porphyromonas | Staphylococcus
Sjögren syndrome 0.3452 1 (33%) : Bacteriodes uniformis 5 (36%) : Alistipes | Bifidobacterium | Faecalibacterium | Porphyromonas | Prevotella
Asthma 0.3452 1 (33%) : Bacteroides 5 (36%) : Bifidobacterium | Corynebacterium | Faecalibacterium | Prevotella | Staphylococcus
Hepatitis B 0.3452 1 (33%) : Bacteroides 5 (36%) : Alistipes | Bifidobacterium | Campylobacter | Corynebacterium | Prevotella
Alcoholism 0.3452 1 (33%) : Bacteroides 5 (36%) : Bifidobacterium | Faecalibacterium | Porphyromonas | Prevotella | Staphylococcus
Osteoarthritis 0.3333 2 (67%) : Bacteriodes uniformis | Bacteroides fragilis 0 (0%)
Functional dyspepsia 0.3333 2 (67%) : Bacteriodes uniformis | Bacteroides 0 (0%)
Multiple system atrophy 0.3333 2 (67%) : Bacteroides | Bacteroides fragilis 0 (0%)
Psoriasis 0.3095 1 (33%) : Bacteroides 4 (29%) : Alistipes | Anaerococcus | Faecalibacterium | Staphylococcus
Irritable bowel syndrome 0.3095 1 (33%) : Bacteroides 4 (29%) : Alistipes | Bifidobacterium | Faecalibacterium | Staphylococcus
Non-alcoholic fatty liver disease 0.3095 1 (33%) : Bacteroides 4 (29%) : Alistipes | Faecalibacterium | Prevotella | Pseudobutyrivibrio
Inflamatory bowel disease 0.3095 1 (33%) : Bacteroides fragilis 4 (29%) : Alistipes | Bifidobacterium | Faecalibacterium | Prevotella
Chronic kidney disease 0.3095 1 (33%) : Bacteroides 4 (29%) : Bifidobacterium | Corynebacterium | Faecalibacterium | Prevotella
Cirrhosis 0.3095 1 (33%) : Bacteroides 4 (29%) : Bifidobacterium | Campylobacter | Prevotella | Veillonellaceae
Celiac Disease 0.3095 1 (33%) : Bacteroides 4 (29%) : Bifidobacterium | Prevotella | Staphylococcus | Veillonellaceae
Pancreatitis 0.3095 1 (33%) : Bacteroides 4 (29%) : Bifidobacterium | Corynebacterium | Faecalibacterium | Prevotella
Smoking 0.3095 1 (33%) : Bacteroides 4 (29%) : Corynebacterium | Porphyromonas | Prevotella | Staphylococcus
Systemic lupus erythematosus 0.2738 1 (33%) : Bacteriodes uniformis 3 (21%) : Bifidobacterium | Prevotella | Pseudobutyrivibrio
Alzheimer's disease 0.2738 1 (33%) : Bacteroides 3 (21%) : Alistipes | Bifidobacterium | Veillonellaceae
Major depressive disorder 0.2738 1 (33%) : Bacteroides 3 (21%) : Bifidobacterium | Faecalibacterium | Prevotella
Parkinson's Disease 0.2738 1 (33%) : Bacteroides 3 (21%) : Corynebacterium | Faecalibacterium | Prevotella
Interstitial cystitis 0.2738 1 (33%) : Bacteroides 3 (21%) : Campylobacter | Faecalibacterium | Prevotella
Coronary artery disease 0.2738 1 (33%) : Bacteroides 3 (21%) : Faecalibacterium | Fusicatenibacter | Staphylococcus
Spinal cord injury 0.2738 1 (33%) : Bacteroides 3 (21%) : Faecalibacterium | Prevotella | Pseudobutyrivibrio

[Coverage Factors (Overlap > 0.10)]

FactorOverlapCommon increased OrganismCommon decreased Organism
Low FODMAP diet 0.2024 1 (33%) : Bacteroides 1 (7%) : Bifidobacterium
Vaginally delivery 0.1667 1 (33%) : Bacteroides 0 (0%)
Sugar intake 0.1667 1 (33%) : Bacteroides fragilis 0 (0%)
Milk Formula-feeding 0.1667 1 (33%) : Bacteroides 0 (0%)